Decision Resources Group is organizing the Competitive Landscape Seminar Series: Biologics and Biosimilars on May 2, 2013. The event will be held at Hotel Solamar in San Diego, California.
This high-value, one-day seminar has been developed specifically for biopharmaceutical market research executives as well as biologics and biosimilars product teams. Expert analysts from Decision Resources Group companies–Decision Resources and BioTrends Research Group–will share their latest research findings on key biologics and biosimilars trends.
Andrew Merron, Ph.D., Director of the Biosimilars Advisory Service at Decision Resources Group, a recognized expert in the area of biologics and biosimilars, explained the timeliness of the seminar. “Though the first generation of biosimilar products experienced mixed commercial success in Europe, substantial commercial opportunity remains for future biosimilar agents across a wide variety of indications and new biologics continue to carve out niches and evolve current standards of care,” said Dr. Merron.
Presentations at the seminar will address market trends and opportunities. Dr. Merron noted, “Sales of biologics have continued to grow globally despite increasing competition from biosimilars. However, developers of new branded biologics are now challenged to demonstrate clinical differentiation and developers of biosimilars are challenged to meet robust clinical comparability requirements.”
This seminar is intended for pharmaceutical professionals involved in market research, business development and competitive intelligence.